Tirzepatide tends to produce greater weight loss on average (20.9% in SURMOUNT-1 versus 14.9% in STEP 1), which may translate to slightly more pronounced menstrual effects
"Thus, it helps with brightening and calming of the skin," King explains
In published trials the triple agonist produced larger average weight reductions but that comparison is cross-trial, not head-to-head , which matters more than most write-ups admit
doi: 10.1038/s41586-019-1707-0 99 YangYLinYHanZWangBZhengWWeiL
Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials
A few, including Wegovy, Zepbound, and Saxenda (liraglutide), are FDA-approved for weight loss